Cardiopoietic cell therapy for advanced ischemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial

MLA

Bartunek, Jozef, et al. Cardiopoietic Cell Therapy for Advanced Ischemic Heart Failure : Results at 39 Weeks of the Prospective, Randomized, Double Blind, Sham-Controlled CHART-1 Clinical Trial. Jan. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bd476f209e3b7147f64f775093581130&authtype=sso&custid=ns315887.

APA

Bartunek, J., Terzic, A., Davison, B. A., Filippatos, G. S., Radovanovic, S., Beleslin, B., Merkely, B., Musialek, P., Wojakowski, W., Andreka, P., Horvath, I. G., Katz, A., Dolatabadi, D., El Nakadi, B., Arandjelovic, A., Edes, I., Seferovic, P. M., Obradovic, S., Vanderheyden, M., … Potter, V. (2017). Cardiopoietic cell therapy for advanced ischemic heart failure : results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.

Chicago

Bartunek, Jozef, Andre Terzic, Beth A Davison, Gerasimos S Filippatos, Slavica Radovanovic, Branko Beleslin, Bela Merkely, et al. 2017. “Cardiopoietic Cell Therapy for Advanced Ischemic Heart Failure : Results at 39 Weeks of the Prospective, Randomized, Double Blind, Sham-Controlled CHART-1 Clinical Trial,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....bd476f209e3b7147f64f775093581130&authtype=sso&custid=ns315887.